About this trial

This research is studying a device already approved by the Food and Drug Administration (FDA) to treat wound closures. Researchers are studying a large group of people to continue to learn information about the safety of the STRATAFIX suture and how people's bodies react to using it over a long period of time. This research will provide additional information about using STRATAFIX sutures to close surgical wounds.

Eligibility criteria

Qualifiers

Elective or emergent surgical approaches for cranial or spine neurosurgical approaches, requiring sutures for wound closure, requiring multilayer wound closure

Disqualifiers

Patients with prior surgical wound dehiscence or infection

Patients with allergy to suture material

Trial design

Treatments tested in this trial

  • STRATAFIX PDS and Monocryl suture

Treatment groups

160 Participants
are divided into 1 treatment group

Locations

1
University of Michigan Health Sparrow48912, LansingMichigan, United States

Sponsors and collaborators

University of Michigan

Lead sponsor

Johnson & Johnson

Collaborator